Experts from Capsugel and Catalent discuss the rationale of using lipid0basd formulations to improve the oral bioavailability of poorly soluble drugs. Rafe Swan/Cultura/Getty Images Poor solubility ...

Absorption, distribution, metabolism, and excretion (ADME) are four main processes that demonstrate how a drug behaves after being administered. Therefore, ADME is key in defining a compound’s ...

Hovione has expanded its oral drug delivery toolkit. Working with Zerion Pharma, the company plans to commercialize technology for overcoming the common problem of low drug solubility. Formulations ...

Although efforts have been made to improve solubility, many poorly soluble drugs still reach the market. Peter Nielsen discusses new developments in solubilisation technology, which could help those ...

A common, economic, and easy method of administering drugs is orally, by swallowing a pill or capsule. But oral administration is the most complex way for the human body to absorb an active ...

NEW YORK, Oct. 27, 2025 /CNW/ -- The global oncology market is rapidly shifting toward smarter drug-delivery systems that enhance efficacy, reduce toxicity and improve patient outcomes. Traditional ...

Earlier this year, Hovione announced a partnership with a Danish firm that has developed a whey protein–based excipient meant to enhance spray-dry dispersions. Hovione saw in Zerion Pharma’s ...

Bioavailability is a key parameter of a drug’s behavior and is determined during pre-clinical development. It is the fraction of a compound that reaches systemic circulation and is important for ...

Human intestinal absorption (HIA) and human oral bioavailability are two important ADME properties in drug design. We built some in-silico models for classification of human intestinal absorption (HIA ...

The physical stability and bioavailability of a fixed-dose combination (FDC) drug containing four anti-TB medicines — rifampicin, isoniazid, pyrazinamide and ethambutol — has been vastly improved from ...